| 08:00 – 10:30 | Session: Pathogenesis Chair: Denes Pall |
| 08:00 – 08:30 | Insights Into Hypertension in Children and Adolescents in Africa: The Role of Salt Sensitivity; Brian Rayner, South Africa |
| 08:30 – 09:00 | Perinatal Programming; Julie Ingelfinger, USA |
| 09:00 – 09:30 | Immunology of Hypertension In Children and Adolescents; Mietek Litwin, Poland |
| 09:30 – 10:00 | Genomics of Hypertension with a Focus on Children and Adolescents; Anna Dominiczak, UK |
| 10:00 - 10:30 | The Prevalence of Hypertension In Children and Adolescents In Europe; Denes Pall, Hungary |
| 11:00 – 13:30 | Session: Assessment of Target Organ damage and Risk Profiling Chair: Elke Wuhl |
| 11:00 – 11:30 | Is White Coat Hypertension Benign in Children and Adolescents?; Denes Pall, Hungary |
| 11:30 – 12:00 | Isolated Systolic Hypertension: To Treat or not to Treat?; Empar Lurbe, Spain |
| 12:00 – 12:30 | Impact of Hypertension in the Kidney; Elke Wuhl, Germany |
| 12:30 – 13:00 | Cardiorespiratory Fitness in Obese Adolescents ; Pau Redon, Spain |
| 13:00 – 13:30 | Impact of Hypertension in the Heart; Thomas Seeman, Czech Republic |
| 14:30 – 17:00 | Session: Hypertension with Comorbidities Chair: Stella Stabouli |
| 14:30 – 15:00 | Management of Hypertension in Chronic Kidney Disease – Implications of The ESCAPE Study; Elke Wuhl, Germany |
| 15:00 – 15:30 | Treatment of Metabolic Risk Factors in Children and Adolescents; Stella Stabouli, Greece |
| 15:30 – 16:00 | Treating Hypertension in Kidney Transplant Recipients; Mark Mitsnefes, USA |
| 16:00 – 16:30 | Social Well-Being in Adolescents with Hypertension; Kennedy Cruickshank, UK |
| 16:30 – 17:00 | The Role of Bariatric Surgery in Adolescents; Mark Mitsnefes, USA |
